The association between soluble CD40 ligand and the frequency of pain episodes in the past year in the SS/SD/Sβ0 thalassemia group suggests that platelet activation may contribute to the pathogenesis of acute pain episodes in SCD. This evidence concerns the gene CD40LG and thalassemia.